Open AccessCARDIOVASCULAR DISEASE IN COVID-19 PATIENTS. PART 1.
Author(s) -
V. S. Holyshko,
V. A. Snezhitskiy,
N. V. Matsiyeuskaya
Publication year - 2020
Publication title -
žurnal grodnenskogo gosudarstvennogo medicinskogo universiteta
Language(s) - English
Resource type - Journals
eISSN - 2413-0109
pISSN - 2221-8785
DOI - 10.25298/2221-8785-2020-18-6-643-647
Subject(s) - covid-19 , disease , medicine , pandemic , exacerbation , intensive care medicine , decompensation , concomitant , infectious disease (medical specialty)
The COVID-19 pandemic caused by SARS-CoV-2 is the greatest medical problem of our time. The presence of concomitant cardiovascular pathology in a patient predisposes to a severe course and the formation of adverse outcomes of COVID-19. It is currently known that SARS-CoV-2 infection leads, on the one hand, to exacerbation and decompensation of the patient's cardiovascular disease, on the other hand, it is the origin of acute cardiovascular pathology. Understanding the impact of COVID-19 on the cardiovascular system is essential for providing comprehensive care to critically ill patients. In this review, we summarize the rapidly changing data on cardiovascular damage associated with COVID-19.